Is REGENXBIO Inc. (RGNX) a Buy, Sell, or Hold?
REGENXBIO Inc.
NASDAQ:RGNX
$12.29 USD
-$0.46 (-3.61%)
- Volume
- 1.57M
- Average Volume
- 1.95M
- Market Capitalization
- $635.36M
- P/E Ratio
- -2.19
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $16.19
- Year Low
- $5.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.62
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
30
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 638.86K
RGNX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
RGNX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Simpson Curran | director, officer: Chief Executive Officer | 2026-06-30 | A-Award | 10.18 | 2026-07-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-12-31 | A-Award | 6.9955 | 2026-07-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2026-07-01 | F-InKind | 13.09 | 2026-07-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-02 | M-Exempt | 7.86 | 2026-07-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-02 | S-Sale | 13.64 | 2026-07-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-02 | M-Exempt | 7.86 | 2026-07-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-01 | M-Exempt | 7.86 | 2026-07-01 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-01 | S-Sale | 12.86 | 2026-07-01 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-06-29 | S-Sale | 11.04 | 2026-07-01 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-07-01 | M-Exempt | 7.86 | 2026-07-01 |
| Tasse Daniel | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| Tasse Daniel | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| STUMP DAVID C | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| STUMP DAVID C | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Zachary Jennifer | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| Zachary Jennifer | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Mills Kenneth T. | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Mills Kenneth T. | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| MIGAUSKY GEORGE V | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| MIGAUSKY GEORGE V | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| KARABELAS ARGERIS N | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| KARABELAS ARGERIS N | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Glucksmann Alexandra | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| Glucksmann Alexandra | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Fox Allan M. | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| Fox Allan M. | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| Bennett Jean | director | 2026-05-29 | A-Award | 7.01 | 2026-06-02 |
| Bennett Jean | director | 2026-05-29 | A-Award | 0 | 2026-06-02 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-05-11 | S-Sale | 11.02 | 2026-05-13 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-03-10 | S-Sale | 10.35 | 2026-03-12 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | 2026-02-01 | F-InKind | 11.16 | 2026-02-03 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-02-01 | F-InKind | 11.16 | 2026-02-03 |
| Mills Kenneth T. | director | 2026-01-27 | M-Exempt | 13.09 | 2026-01-29 |
| Mills Kenneth T. | director | 2026-01-27 | F-InKind | 13.41 | 2026-01-29 |
| Mills Kenneth T. | director | 2026-01-27 | M-Exempt | 13.09 | 2026-01-29 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-01-06 | A-Award | 0 | 2026-01-08 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-01-06 | A-Award | 14.18 | 2026-01-08 |
| Malzahn Craig | officer: Chief Technology Officer | 2026-01-06 | A-Award | 0 | 2026-01-08 |
| Malzahn Craig | officer: Chief Technology Officer | 2026-01-06 | A-Award | 14.18 | 2026-01-08 |
| Simpson Curran | director, officer: Chief Executive Officer | 2026-01-06 | A-Award | 0 | 2026-01-08 |
| Simpson Curran | director, officer: Chief Executive Officer | 2026-01-06 | A-Award | 14.18 | 2026-01-08 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | 2026-01-06 | A-Award | 0 | 2026-01-08 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | 2026-01-06 | A-Award | 14.18 | 2026-01-08 |
| Chan Mitchell | officer: Chief Financial Officer | 2026-01-06 | A-Award | 0 | 2026-01-08 |
| Chan Mitchell | officer: Chief Financial Officer | 2026-01-06 | A-Award | 14.18 | 2026-01-08 |
| Simpson Curran | director, officer: Chief Executive Officer | 2026-01-02 | F-InKind | 14.4 | 2026-01-06 |
| Malzahn Craig | officer: Chief Technology Officer | 2026-01-02 | F-InKind | 14.4 | 2026-01-06 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | 2026-01-02 | F-InKind | 14.4 | 2026-01-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2026-01-02 | F-InKind | 14.4 | 2026-01-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-10-09 | S-Sale | 12.62 | 2025-10-10 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-09-29 | S-Sale | 10.03 | 2025-10-01 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-09-10 | S-Sale | 10.02 | 2025-09-12 |
| Malzahn Craig | officer: Chief Technology Officer | 2025-09-01 | F-InKind | 8.93 | 2025-09-03 |
| Chan Mitchell | officer: Chief Financial Officer | 2025-09-01 | F-InKind | 8.93 | 2025-09-03 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | 2025-08-01 | F-InKind | 8.19 | 2025-08-04 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-07-01 | F-InKind | 8.23 | 2025-07-03 |
| Fox Allan M. | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| Fox Allan M. | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Zachary Jennifer | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| Zachary Jennifer | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Tasse Daniel | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| Tasse Daniel | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| STUMP DAVID C | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| STUMP DAVID C | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Mills Kenneth T. | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Mills Kenneth T. | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| MIGAUSKY GEORGE V | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| MIGAUSKY GEORGE V | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Glucksmann Alexandra | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| Glucksmann Alexandra | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| KARABELAS ARGERIS N | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| KARABELAS ARGERIS N | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Bennett Jean | director | 2025-05-30 | A-Award | 8.85 | 2025-06-03 |
| Bennett Jean | director | 2025-05-30 | A-Award | 0 | 2025-06-03 |
| Mills Kenneth T. | director | 2025-05-12 | M-Exempt | 3.76 | 2025-05-14 |
| Mills Kenneth T. | director | 2025-05-12 | S-Sale | 7.9141 | 2025-05-14 |
| Mills Kenneth T. | director | 2025-05-12 | M-Exempt | 3.76 | 2025-05-14 |
| Christmas Patrick J. | officer: Chief Legal Officer | 2025-02-01 | F-InKind | 8.07 | 2025-04-04 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2025-02-01 | F-InKind | 8.07 | 2025-04-04 |
| Danos Olivier | officer: Chief Scientific Officer | 2025-02-01 | F-InKind | 8.07 | 2025-04-04 |
| Mills Kenneth T. | director | 2025-03-27 | M-Exempt | 3.76 | 2025-03-31 |
| Mills Kenneth T. | director | 2025-03-27 | M-Exempt | 3.76 | 2025-03-31 |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 0 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 22.25 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 18.34 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 7.86 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 44.97 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 34.31 | 2025-03-24 | |
| Malzahn Craig | officer: Chief Technology Officer | 2025-03-13 | 40.68 | 2025-03-24 | |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-01-02 | A-Award | 7.86 | 2025-01-14 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2025-01-02 | A-Award | 0 | 2025-01-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2025-01-02 | F-InKind | 7.73 | 2025-01-06 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2025-01-02 | A-Award | 7.86 | 2025-01-06 |
| Danos Olivier | officer: Chief Scientific Officer | 2025-01-02 | A-Award | 0 | 2025-01-06 |
| Danos Olivier | officer: Chief Scientific Officer | 2025-01-02 | F-InKind | 7.73 | 2025-01-06 |
| Danos Olivier | officer: Chief Scientific Officer | 2025-01-02 | A-Award | 7.86 | 2025-01-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-01-02 | A-Award | 7.86 | 2025-01-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-01-02 | A-Award | 0 | 2025-01-06 |
| Simpson Curran | director, officer: Chief Executive Officer | 2025-01-02 | F-InKind | 7.73 | 2025-01-06 |
| Chan Mitchell | officer: Chief Financial Officer | 2025-01-02 | A-Award | 7.86 | 2025-01-06 |